2-Thiophenecarboxaldehyde Oxime

2-Thiophenecarboxaldehyde Oxime

SCHEMBL2160982

O/N=C\c1cccs1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Thiophenecarboxaldehyde Oxime SCHEMBL3964412 1.00
2-Thiophenecarboxaldehyde Oxime SCHEMBL2160985 1.00
2-Thiophenecarboxaldehyde Oxime SCHEMBL29417484 0.98
2-Thiophenecarboxaldehyde Oxime SCHEMBL27987220 0.90 SMN1; SMN2 (0.55)
SCHEMBL1256043 0.80 SMN1; SMN2 (1.00)
SCHEMBL6261321 0.76
SCHEMBL3656290 0.76
SCHEMBL9653560 0.76
SCHEMBL8946058 0.76
SCHEMBL8946056 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113087722-B Tricyclic isoxazole compound and preparation method and application thereof 中国人民解放军海军军医大学 2023-04-28 CN disclosed
CN-113388600-B Aldoxime dehydratase and application thereof in catalytic synthesis of aromatic nitrile compounds 杭州师范大学 2022-05-27 CN disclosed
CN-113388600-A Aldoxime dehydratase and application thereof in catalytic synthesis of aromatic nitrile compounds 杭州师范大学 2021-09-14 CN disclosed
CN-103864754-B Five-membered azole heterocycle compound and preparation method thereof, pharmaceutical composition and purposes 中国科学院上海药物研究所 2016-12-21 CN disclosed
CN-103864754-A Five-membered azole heterocycle compound, preparation method, drug composition and use thereof SHANGHAI INST MATERIA MEDICA 2014-06-18 CN disclosed
US-8440706-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-14 US disclosed
US-8372873-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-02-12 US disclosed
US-20110182856-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-28 US disclosed
US-7985762-B2 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-26 US disclosed
US-20110165120-A1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-07-07 US disclosed
US-5602160-A MUSCLE RELAXANT MITSUI TOATSU CHEMICALS INCORPORATED (JP) 1997-02-11 US disclosed
US-5498619-A MUSCLE RELAXANTS, POLLAKIUREA CURING AGENTS AND MUSCLE SPASMS MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1996-03-12 US disclosed
EP-0414391-B1 Aminoketone derivatives and use thereof MITSUI TOATSU CHEMICALS (JP) 1995-03-15 EP disclosed
US-5338857-A Muscle relaxant MITSUI TOATSU CHEMICALS INCORPORATED (JP) 1994-08-16 US disclosed
EP-0588785-A1 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-03-30 EP disclosed
US-5185363-A Administering for treatment of inflammatory diseases ABBOTT LABORATORIES (US) 1993-02-09 US disclosed
EP-0588785-A4 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS. ABBOTT LAB (US) 1991-12-30 EP disclosed
US-5006515-A Immunology disorders, antitumor agent HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-09 US disclosed
EP-0414391-A2 Aminoketone derivatives and use thereof MITSUI TOATSU CHEMICALS, Inc. (JP) 1991-02-27 EP disclosed
WO-1990012008-A1 UREA BASED LIPOXYGENASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1990-10-18 WO disclosed